0001127602-23-026005.txt : 20231017
0001127602-23-026005.hdr.sgml : 20231017
20231017170812
ACCESSION NUMBER: 0001127602-23-026005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHIDSEY JOHN
CENTRAL INDEX KEY: 0001128484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10315
FILM NUMBER: 231330301
MAIL ADDRESS:
STREET 1: C/O CENDANT
STREET 2: 9 WEST 57TH ST
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Encompass Health Corp
CENTRAL INDEX KEY: 0000785161
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 630860407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9001 LIBERTY PARKWAY
CITY: BIRMINGHAM
STATE: AL
ZIP: 35242
BUSINESS PHONE: 205-967-7116
MAIL ADDRESS:
STREET 1: 9001 LIBERTY PARKWAY
CITY: BIRMINGHAM
STATE: AL
ZIP: 35242
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHSOUTH CORP
DATE OF NAME CHANGE: 19950113
FORMER COMPANY:
FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2023-10-16
0000785161
Encompass Health Corp
EHC
0001128484
CHIDSEY JOHN
6915 GRANADA BOULEVARD
CORAL GABLES
FL
33146
1
0
Encompass Health Common Stock
2023-10-16
4
A
0
222
0
A
161181
D
Encompass Health Common Stock
2023-10-17
4
A
0
541
64.58
A
161722
D
Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 16, 2023, Encompass Health paid a dividend on its common stock of $0.15 per share and the closing price was $63.77. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment.
The Directors Deferred Stock Investment Plan of the Company is a non-qualified deferral plan adopted and approved by the Board of Directors, effective November 1, 2007, allowing non-employee directors to make elections during 2022 to defer fixed percentages of their director fees for 2023. The amount each participant defers under the Plan is deducted, on a quarterly basis, from the directors fees the participant would otherwise have received in cash. The deferred fees fund the purchase of the Company's common stock by the Plan administrator in the market for the account of each participating director, and under the terms of the Plan, such stock is entitled to cash dividends that are reinvested by the Plan administrator in the Company's common stock. The number reported represents shares purchased with the quarterly deferred fees and the dividend of $0.15 per share paid on October 16, 2023.
/s/ Patrick Darby, attorney-in-fact for John W. Chidsey
2023-10-17